Company Name, Ticker, Industry, else..

Bionik Laboratories Corp (BNKL)

Sector • Healthcare Industry • Medical Equipment & Supplies

Industry • Medical Equipment & Supplies

Sector • Healthcare

Bionik Laboratories 's

Name: Bionik Laboratories Corp Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BNKL Sales vs. its Competitors Q4 2023

Comparing the current results to its competitors, Bionik Laboratories reported Revenue increase in the 4 quarter 2023 by 158.15 % year on year.
The sales growth was above Bionik Laboratories 's competitors' average revenue growth of 8.44 %, achieved in the same quarter.

• List of BNKL Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Bionik Laboratories Corp , slower than the average decrease reported by the company's competitors of -1.74 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -1.74 %

<< BNKL Stock Performance Comparisons

<< See the full list of BNKL competitors

Overall company Market Share Q4 2023

Due to outstanding performance in Overall company, revenue grew by 158.15 % Bionik Laboratories Corp improved its market share, to approximately 0 %. << More on BNKL Market Share.

*Market share is calculated based on total revenue.

BNKL's Stock Performance relative to its Competitors

Publicly Traded Peers of Bionik Laboratories Corp

Sigyn Therapeutics Inc
Share Performance

0.00%

One Year

Sigyn Therapeutics Inc

Profile

Sigyn Therapeutics Inc has a business model focused on developing novel medical therapeutics for the treatment of life-threatening inflammatory conditions.

More about Sigyn Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ - mill.	$ - mill.	$ -3.221 mill.

Medtronic Plc
Share Performance

-2.42%

Over The Past 5 Days

Medtronic Plc

Profile

Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.

More about Medtronic Plc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 116,893.175 mill.	$ 35,483.000 mill.	$ 4,639.000 mill.

Lifeward ltd
Share Performance

+6.57%

30 Days

Lifeward ltd

Profile

The company acquires and integrates businesses, including AlterG, to develop and commercialize products.

More about Lifeward ltd 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 20.863 mill.	$ 21.822 mill.	$ -30.830 mill.

Intuitive Surgical Inc
Share Performance

-19.66%

One Year

Intuitive Surgical Inc

Profile

Intuitive Surgical Incs business model focuses on delivering robotic surgical systems, particularly the da Vinci Surgical System, which facilitates minimally invasive surgeries. Revenue is generated through system sales, instruments, accessories, and services, including training and maintenance for healthcare providers.

More about Intuitive Surgical Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 134,652.078 mill.	$ 11,296.300 mill.	$ 3,157.900 mill.

Ekso Bionics Holdings Inc
Share Performance

+40.64%

This Quarter

Ekso Bionics Holdings Inc

Profile

Ekso Bionics Holdings Inc's business model centers around developing and manufacturing exoskeleton systems that enhance human mobility and strength. These advanced wearable technologies are designed to assist individuals with limited mobility due to various medical conditions or physical impairments.

More about Ekso Bionics Holdings Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 42.043 mill.	$ 11.113 mill.	$ -15.689 mill.

4 more competitors available

Sources: Bionik Laboratories Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, August 31, 2026 2:10 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Bionik Laboratories Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.